Am. J. Respir. Crit. Care Med., Volume 158, Number 1, July 1998, 84-91

Endobronchial Biopsy and Bronchoalveolar Lavage in Stable Lung Transplant Recipients and Chronic Rejection

CHRIS WARD, GREGORY I. SNELL, LING ZHENG, BERNADETTE ORSIDA, HELEN WHITFORD, TREVOR J. WILLIAMS, and E. HAYDN WALTERS

Department of Respiratory Medicine, Alfred Hospital, and Monash University Medical School, Melbourne, Australia

We have obtained endobronchial biopsies (EBB), bronchoalveolar lavage (BAL), and transbronchial biopsies (TBB) in 17 stable lung transplant recipients (sLTR), 8 subjects with physiologic evidence of chronic rejection (BOS), and 9 normal subjects. A striking finding was the marked neutrophilia in BAL samples from patients with BOS, in the carefully screened absence of infection. A statistically higher neutrophil count was also present in the sLTR group relative to the normal group. Median BAL neutrophil count in BOS was 100 × 10³/ml, range 13-1,661 10³/ml (p < 0.001 relative to normal subjects and sLTR). Median BAL neutrophil count in sLTR was 7 × 10³/ml, range 1-81 10³/ml (p < 0.01 relative to normal subjects). Normal subjects had a median BAL neutrophil count of 3 × 10³/ml, range 1-7 10³/ml. There was evidence of a predominance of CD8 lymphocytes in BAL from sLTR and BOS with a lower CD4/CD8 ratio in both compared to normal subjects (p < 0.05). EBB mononuclear cell counts, class II major histocompatibility complex expression, and T-cell activation markers were normal in BOS, in contrast to the sLTR group. Our data may be consistent with BOS, representing a relative resolution of an active mononuclear cell chronic inflammation, perhaps at the expense of airway fibrosis. The relevance of the BAL neutrophilia and its role in BOS pathogenesis need further longitudinal investigation.

This article has been cited by other articles:

				R. L. Anderson, P. S. Hiemstra, C. Ward, I. A. Forrest, D. Murphy, D. Proud, J. Lordan, P. A. Corris, and A. J. Fisher Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Eur. Respir. J., September 1, 2008; 32(3): 670 - 677. [Abstract] [Full Text] [PDF]

				D. M. Murphy, I. A. Forrest, P. A. Corris, G. E. Johnson, T. Small, D. Jones, A. J. Fisher, J. J. Egan, T. E. Cawston, C. Ward, et al. Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L592 - L599. [Abstract] [Full Text] [PDF]

				D.-J. SLEBOS, J. SCHOLMA, H. MARIKE BOEZEN, G. H. KOETER, W. VAN DER BIJ, D. S. POSTMA, and H. F. KAUFFMAN Longitudinal Profile of Bronchoalveolar Lavage Cell Characteristics in Patients with a Good Outcome after Lung Transplantation Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 501 - 507. [Abstract] [Full Text] [PDF]

				M. Reynaud-Gaubert, P. Thomas, R. Gregoire, M. Badier, P. Cau, J. Sampol, R. Giudicelli, and P. Fuentes Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients Eur. J. Cardiothorac. Surg., January 1, 2002; 21(1): 60 - 66. [Abstract] [Full Text] [PDF]

				C. Agostini, F. Calabrese, F. Rea, M. Facco, A. Tosoni, M. Loy, G. Binotto, M. Valente, L. Trentin, and G. Semenzato CXCR3 and Its Ligand CXCL10 Are Expressed by Inflammatory Cells Infiltrating Lung Allografts and Mediate Chemotaxis of T Cells at Sites of Rejection Am. J. Pathol., May 1, 2001; 158(5): 1703 - 1711. [Abstract] [Full Text] [PDF]

				E. GABBAY, E. HAYDN WALTERS, B. ORSIDA, H. WHITFORD, C. WARD, T. C. KOTSIMBOS, G. I. SNELL, and T. J. WILLIAMS Post-lung Transplant Bronchiolitis Obliterans Syndrome (BOS) Is Characterized by Increased Exhaled Nitric Oxide Levels and Epithelial Inducible Nitric Oxide Synthase Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2182 - 2187. [Abstract] [Full Text]

				J. SCHOLMA, D.-J. SLEBOS, H. MARIKE BOEZEN, J. W. K. van den BERG, W. van der BIJ, W. J. de BOER, G. H. KOËTER, W. TIMENS, H. F. KAUFFMAN, and D. S. POSTMA Eosinophilic Granulocytes and Interleukin-6 Level in Bronchoalveolar Lavage Fluid Are Associated with the Development of Obliterative Bronchiolitis after Lung Transplantation Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2221 - 2225. [Abstract] [Full Text]

				C. T. LEONARD, P. M. SOCCAL, L. SINGER, G. J. BERRY, J. THEODORE, P. G. HOLT, R. L. DOYLE, and G. D. ROSEN Dendritic Cells and Macrophages in Lung Allografts . A Role in Chronic Rejection? Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1349 - 1354. [Abstract] [Full Text]

				L. Zheng, E H. Walters, C. Ward, N. Wang, B. Orsida, H. Whitford, T. J Williams, T. Kotsimbos, and G. I Snell Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation Thorax, January 1, 2000; 55(1): 53 - 59. [Abstract] [Full Text]

				E. GABBAY, E. HAYDN WALTERS, B. ORSIDA, H. WHITFORD, C. WARD, T. C. KOTSIMBOS, G. I. SNELL, and T. J. WILLIAMS In Stable Lung Transplant Recipients, Exhaled Nitric Oxide Levels Positively Correlate with Airway Neutrophilia and Bronchial Epithelial iNOS Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 2093 - 2099. [Abstract] [Full Text]